Inflammation is a complex process that contributes to both tissue damage and repair. Lipopolysaccharide is a constituent of cell walls of gram- negative bacteria. It is a potent activator of humoral and cellular immunity and produces numerous changes in cell function, including enhancement of synthesis of the complement proteins factor B and C3 and the interleukins, IL-1 and IL-6. We have recognized a developmentally regulated response to LPS in both fibroblasts and peripheral blood monocytes. Fetal cells to not increase either synthesis of the proteins or levels of the mRNA. Neonatal cells (fibroblasts and monocytes) do respond to LPS stimulation with increased amounts of specific mRNAs for factor B and C3, but synthesis of the proteins is not initiated. The experiments presented in this application are designed to define the molecular basis of this developmental regulation in human cells. An animal model (mouse) is available for definition of the progression of the responsiveness through gestation and as the animal matures to adulthood. Protein synthesis will be examined by both two-dimensional gel electrophoresis to define the scope of the developmentally regulated differences in LPS responsiveness and by SDS-polyacrylamide gel electrophoresis to study specific proteins produced in these cells. Northern blot analysis will be used to study level regulation of changes in synthesis of specific proteins. Translation regulation of the LPS-induced mRNAs in neonatal cells will be studied using in vitro translation. Human newborns are particularly susceptible to E. coli and other gram negative infections. This susceptibility may be related tot he qualitative and quantitative decrease in response to LPS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK026609-08
Application #
3227965
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1980-12-01
Project End
1995-01-31
Budget Start
1991-02-01
Budget End
1992-01-31
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ernst, S C; Circolo, A; Davis 3rd, A E et al. (1996) Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8. J Immunol 157:405-10
Katz, Y; Gur, S; Aladjem, M et al. (1995) Synthesis of complement proteins in amnion. J Clin Endocrinol Metab 80:2027-32
Strunk, R C; Fleischer, J A; Katz, Y et al. (1994) Developmentally regulated effects of lipopolysaccharide on biosynthesis of the third component of complement and factor B in human fibroblasts and monocytes. Immunology 82:314-20
Kramer, J; Rosen, F S; Colten, H R et al. (1993) Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J Clin Invest 91:1258-62
Garnier, G; Ault, B; Kramer, M et al. (1992) cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression. J Exp Med 175:471-9
Circolo, A; Welgus, H G; Pierce, G F et al. (1991) Differential regulation of the expression of proteinases/antiproteinases in fibroblasts. Effects of interleukin-1 and platelet-derived growth factor. J Biol Chem 266:12283-8
Kramer, J; Katz, Y; Rosen, F S et al. (1991) Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema. J Clin Invest 87:1614-20
Katz, Y; Strunk, R C (1990) Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblasts is decreased by IL-4. J Immunol 144:4675-80
Katz, Y; Strunk, R C (1989) IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. J Immunol 142:3862-7
Katz, Y; Strunk, R C (1988) Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum 31:1365-70

Showing the most recent 10 out of 11 publications